Cbln1 downregulates the formation and function of inhibitory synapses in mouse cerebellar Purkinje cells.
The formation of excitatory and inhibitory synapses must be tightly coordinated to establish functional neuronal circuitry during development. In the cerebellum, the formation of excitatory synapses between parallel fibers and Purkinje cells is strongly induced by Cbln1, which is released from parallel fibers and binds to the postsynaptic δ2 glutamate receptor (GluD2). However, Cbln1's role, if any, in inhibitory synapse formation has been unknown. Here, we show that Cbln1 downregulates the formation and function of inhibitory synapses between Purkinje cells and interneurons. Immunohistochemical analyses with an anti-vesicular GABA transporter antibody revealed an increased density of interneuron-Purkinje cell synapses in the cbln1-null cerebellum. Whole-cell patch-clamp recordings from Purkinje cells showed that both the amplitude and frequency of miniature inhibitory postsynaptic currents were increased in cbln1-null cerebellar slices. A 3-h incubation with recombinant Cbln1 reversed the increased amplitude of inhibitory currents in Purkinje cells in acutely prepared cbln1-null slices. Furthermore, an 8-day incubation with recombinant Cbln1 reversed the increased interneuron-Purkinje cell synapse density in cultured cbln1-null slices. In contrast, recombinant Cbln1 did not affect cerebellar slices from mice lacking both Cbln1 and GluD2. Finally, we found that tyrosine phosphorylation was upregulated in the cbln1-null cerebellum, and acute inhibition of Src-family kinases suppressed the increased inhibitory postsynaptic currents in cbln1-null Purkinje cells. These findings indicate that Cbln1-GluD2 signaling inhibits the number and function of inhibitory synapses, and shifts the excitatory-inhibitory balance towards excitation in Purkinje cells. Cbln1's effect on inhibitory synaptic transmission is probably mediated by a tyrosine kinase pathway.
Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi, Saitama, Japan; Department of Cellular Neurobiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Physiology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Aya
A
Ito-Ishida
Wataru
W
Kakegawa
Kazuhisa
K
Kohda
Eriko
E
Miura
Shigeo
S
Okabe
Michisuke
M
Yuzaki
D000818:Animals; D015536:Down-Regulation; D053444:Inhibitory Postsynaptic Potentials; D007395:Interneurons / Q000378:metabolism / Q000502:physiology; D051379:Mice; D055369:Miniature Postsynaptic Potentials; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D055495:Neurogenesis; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism*; D011689:Purkinje Cells / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D017470:Receptors, Glutamate / Q000235:genetics / Q000378:metabolism; D013569:Synapses / Q000378:metabolism* / Q000502:physiology; D019061:src-Family Kinases / Q000378:metabolism
C092370:Cbln1 protein, mouse; D009419:Nerve Tissue Proteins; D011498:Protein Precursors; D017470:Receptors, Glutamate; C107913:glutamate receptor delta 2; D019061:src-Family Kinases
Purkinje cell; cerebellum; glutamate receptor; inhibitory synapse; interneuron